The average one-year price target for Gilead Sciences (NasdaqGS:GILD) has been revised to $159.01 / share. This is an ...
The average one-year price target for Roivant Sciences (NasdaqGS:ROIV) has been revised to $32.44 / share. This is an ...
Evercore ISI analyst Vijay Kumar raised the firm’s price target on Exact Sciences (EXAS) to $70 from $60 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life ...
BofA analyst Michael Ryskin lowered the firm’s price target on Exact Sciences (EXAS) to $65 from $72 and keeps a Buy rating on the shares. There were “few surprises” in the formal earnings release ...
CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human ...
Cassava Sciences' stock price jumped 15.5% to $27.13, driven by rising short interest, which now accounts for 35.89% of the total float. he company will hold a conference call on August 8 to discuss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results